Lariam (mefloquine)

Lariam contains the active ingredient mefloquine, which is effective against Plasmodium species responsible for malaria. It is particularly useful in regions where malaria parasites have developed resistance to other antimalarial drugs.

Price ₵109.00 /Tablet

Key Product Information

Product description

Description:

Prescription:

Lariam is a prescription-only medication and should be used under the guidance of a healthcare professional.

Therapeutic Category:

Antimalarial agent.

Active Ingredients/Composition:

Mefloquine Hydrochloride: Each tablet contains 250 mg of mefloquine hydrochloride, equivalent to 228 mg of mefloquine base.

Vitamins:

Lariam does not contain added vitamins.

Minerals:

Lariam does not contain added minerals.

Variant:

Lariam is available in tablet form, with each tablet containing 250 mg of mefloquine hydrochloride.

Consume Type:

Oral tablets.

Directions/Usage:

Prevention of Malaria (Prophylaxis):
- Adults and Children Over 45 kg: One 250 mg tablet once weekly. Start one week before entering a malaria-endemic area, continue weekly during the stay, and for four weeks after leaving the area.
Treatment of Malaria:
- Adults: A single dose of 1,250 mg (five 250 mg tablets).

Dosage for children is based on body weight and should be determined by a healthcare provider.

Common Side Effects:

Neurological: Dizziness, headache, balance disturbances.
Psychiatric: Anxiety, depression, mood changes, vivid dreams, insomnia.
Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
Other: Visual disturbances, skin rash.

Seek medical attention if severe side effects occur.

Package Type:

Lariam tablets are typically packaged in blister packs, with the number of tablets varying based on the prescribed regimen.

Storage Advice:

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Safety Advice:

Contraindications: Not recommended for individuals with a history of psychiatric disorders, seizures, or severe liver impairment.
Cautions: Use with caution in individuals with cardiac conditions. Avoid activities requiring alertness (e.g., driving) if experiencing dizziness or visual disturbances.
Pregnancy and Breastfeeding:
Consult a healthcare provider before use.

Product Substitutes: